Compass Therapeutics, Inc. (CMPX) Ownership

$2.10

$0.02 (-0.94%)
Last update: 04:00 PM EST
Day's range
$2.06
Day's range
$2.17

Compass Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 05/15/2025 22.36 M $42.49 M   0.00% 16.25%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 11.05 M $21.00 M   87.33% 8.03%
BLACKSTONE INC. 05/15/2025 10.03 M $19.05 M   0.00% 7.29%
BIOIMPACT CAPITAL LLC 05/15/2025 8.44 M $16.04 M   -1.46% 6.14%
05/15/2025 7.79 M $14.80 M   0.00% 5.66%
BLACKROCK, INC. 05/02/2025 7.11 M $13.51 M   3.22% 5.17%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2025 4.96 M $9.43 B   -14.13% 3.61%
VANGUARD GROUP INC 05/09/2025 4.84 M $9.19 M   2.54% 3.52%
FMR LLC 05/12/2025 4.13 M $7.86 M   -0.05% 3.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 3.98 M $7.55 M   -33.69% 2.89%
VIVO CAPITAL, LLC 05/12/2025 3.56 M $6.76 M   0.00% 2.58%
BLUE OWL CAPITAL HOLDINGS LP 05/15/2025 2.95 M $5.61 M   0.00% 2.15%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 2.36 M $4.49 M   1.32% 1.72%
JPMORGAN CHASE & CO 05/12/2025 2.19 M $4.15 M   702.52% 1.59%
STATE STREET CORP 05/15/2025 1.95 M $3.70 M   2.45% 1.42%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 1.33 M $2.53 M   100.00% 0.97%
SG AMERICAS SECURITIES, LLC 04/15/2025 940.78 K $1.79 M   138.16% 0.68%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2025 874.87 K $1.66 M   100.00% 0.64%
MORGAN STANLEY 05/15/2025 839.18 K $1.59 M   121.68% 0.61%
NORTHERN TRUST CORP 05/13/2025 803.14 K $1.53 M   0.24% 0.58%
MACQUARIE GROUP LTD 05/15/2025 681.54 K $1.30 K   100.00% 0.50%
IKARIAN CAPITAL, LLC 05/15/2025 662.20 K $1.26 M   100.00% 0.48%
CAPTION MANAGEMENT, LLC 05/15/2025 561.20 K $1.07 M   100.00% 0.41%
BAKER BROS. ADVISORS LP 05/15/2025 547.50 K $1.04 M   -64.85% 0.40%
MILLENNIUM MANAGEMENT LLC 05/15/2025 545.09 K $1.04 M   1,509.97% 0.40%
MONASHEE INVESTMENT MANAGEMENT LLC 05/14/2025 448.16 K $851.51 K   0.00% 0.33%
BANK OF AMERICA CORP /DE/ 05/15/2025 383.50 K $728.66 K   239.32% 0.28%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 332.10 K $630.99 K   100.00% 0.24%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 321.50 K $610.85 K   15.40% 0.23%
05/12/2025 304.50 K $578.56 K   100.00% 0.22%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 297.88 K $565.97 K   4.08% 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 253.40 K $481.46 K   100.00% 0.18%
BANK OF NEW YORK MELLON CORP 04/29/2025 243.57 K $462.77 K   2.35% 0.18%
GOLDMAN SACHS GROUP INC 05/16/2025 233.52 K $443.69 K   -40.19% 0.17%
PROPEL BIO MANAGEMENT, LLC 05/15/2025 228.32 K $433.80 K   100.00% 0.17%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 222.51 K $422.76 K   100.00% 0.16%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 212.30 K $403.37 K   100.00% 0.15%
05/15/2025 200.00 K $380.00 K   100.00% 0.15%
HAP TRADING, LLC 05/14/2025 199.80 K $89.74 K   100.00% 0.15%
PANAGORA ASSET MANAGEMENT INC 05/15/2025 170.61 K $324.15 K   -0.50% 0.12%
CITADEL ADVISORS LLC 05/15/2025 169.60 K $322.24 K   100.00% 0.12%
CANTOR FITZGERALD, L. P. 05/15/2025 150.00 K $285.00 K   50.00% 0.11%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 138.80 K $264.02 K   1,148.56% 0.10%
HUDSON BAY CAPITAL MANAGEMENT LP 05/14/2025 134.00 K $254.60 K   100.00% 0.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 131.50 K $249.84 K   140.77% 0.10%
CITIGROUP INC 05/12/2025 131.24 K $249.35 K   66.96% 0.10%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 130.81 K $248.53 K   100.00% 0.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 130.80 K $248.52 K   100.00% 0.10%
RHUMBLINE ADVISERS 05/29/2025 120.03 K $228.05 K   -7.04% 0.09%
SIMPLIFY ASSET MANAGEMENT INC. 05/13/2025 120.00 K $228.00 K   100.00% 0.09%

Compass Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 116 institutional investors and hedge funds held shares of Compass Therapeutics, Inc.. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 22.36 M

TANG CAPITAL MANAGEMENT LLC: 11.05 M

Blackstone Inc.: 10.03 M

BioImpact Capital LLC: 8.44 M

BlackRock, Inc.: 7.11 M

Rock Springs Capital Management LP: 4.96 M

79.07% of Compass Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 111.66 M shares in the last 24 months. This purchase volume represents approximately $234.48 M in transactions.